1. Home
  2. CRSR vs CDNA Comparison

CRSR vs CDNA Comparison

Compare CRSR & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corsair Gaming Inc.

CRSR

Corsair Gaming Inc.

HOLD

Current Price

$10.27

Market Cap

1.3B

Sector

Technology

ML Signal

HOLD

Logo CareDx Inc.

CDNA

CareDx Inc.

HOLD

Current Price

$23.70

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRSR
CDNA
Founded
1994
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Manufacturing
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.1B
IPO Year
2020
2007

Fundamental Metrics

Financial Performance
Metric
CRSR
CDNA
Price
$10.27
$23.70
Analyst Decision
Buy
Buy
Analyst Count
7
6
Target Price
$8.50
$28.00
AVG Volume (30 Days)
3.8M
582.4K
Earning Date
05-07-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
87.37
N/A
EPS
0.11
0.05
Revenue
$1,472,480,000.00
$48,324,000.00
Revenue This Year
N/A
$16.01
Revenue Next Year
$6.90
$11.31
P/E Ratio
$95.23
$446.20
Revenue Growth
11.86
18.93
52 Week Low
$4.48
$10.96
52 Week High
$13.10
$23.24

Technical Indicators

Market Signals
Indicator
CRSR
CDNA
Relative Strength Index (RSI) 63.11 68.05
Support Level $5.30 $15.80
Resistance Level $13.10 N/A
Average True Range (ATR) 0.87 1.01
MACD 0.24 0.11
Stochastic Oscillator 55.98 92.51

Price Performance

Historical Comparison
CRSR
CDNA

About CRSR Corsair Gaming Inc.

Corsair Gaming Inc is engaged in the business of providing high-performance gear for gamers and content creators. The product portfolio includes Cases, Keyboards, Mice, Headsets, Power Supplies, Gaming Computers, Gaming Chairs, Mousepads, and other related products. The company operates in two segments namely, Gamer and Creator peripherals, which is the key revenue-generating segment; and Gaming Components and Systems. Geographically, the group derives revenue from the United States (U.S.), Americas (excluding U.S.) , Europe and the Middle East, and the Asia Pacific, of which maximum revenue is generated from United States (U.S.).

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

Share on Social Networks: